Dr. Saion Sinha has been leading cutting edge research into difficult scientific problems since he was a student studying physics at the Indian Institute of Technology in Kharagpur, India. He received his PhD from the University of Kentucky and serves as a professor and researcher at the University of New Haven.

After developing tests for Lyme disease and pioneering a patent for the use of carbon nanowire in testing DNA, Dr. Sinha founded 12-15 Molecular Diagnostics in 2016. The organization has studied a range of airborne disease and viruses in animals.

In 2018, the 12-15 team developed the advanced technique of hybridization, which uses carbon-based nanomaterial to process biofluids electronically. Using this technology, the 12-15 team has developed Veralize, a device that enables a 7-minute saliva test for COVID-19 with the accuracy of PCR tests.

There is a serious need for rapid testing right now. We will continue improving our technology to make a difference in people’s lives.